Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TADALAFIL 5MG TABLET Resolved 2024-03-28 2024-04-25 223859
TEVA-TELMISARTAN 80MG TABLET Resolved 2024-01-11 2024-04-25 215728
TEVA-TELMISARTAN 40MG TABLET Resolved 2023-07-20 2024-04-25 199393
TEVA-FLUVASTATIN 20MG CAPSULE Resolved 2023-11-03 2024-04-25 209111
TEVA-BETAHISTINE 24MG TABLET Resolved 2024-02-01 2024-04-25 218129
TEVA-OLANZAPINE 5MG TABLET Resolved 2024-03-28 2024-04-25 223844
TEVA-SERTRALINE 100MG CAPSULE Resolved 2024-03-21 2024-04-25 222938
TEVA-NAPROXEN 500MG TABLET Resolved 2024-02-01 2024-04-25 218123
TEVA-CEPHALEXIN 250 250MG POWDER FOR SUSPENSION Resolved 2023-08-03 2024-04-25 200864
ACT DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-01-25 2024-04-25 217240
ACT DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-02-01 2024-04-25 218145
TEVA-TADALAFIL 2.5MG TABLET Actual shortage 2024-04-25 2024-04-25 226177
TEVA-BUSPIRONE 10MG TABLET Actual shortage 2024-04-25 2024-04-25 226174
TEVA-ECTOSONE 0.1% LOTION Actual shortage 2024-04-25 2024-04-25 226171
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-11 2024-04-25 215760
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-04-25 215751
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-04-25 221534
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-28 2024-04-25 223862
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-04-05 2024-04-25 224445
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-03-07 2024-04-25 221546

Showing 1 to 20 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
EPTIFIBATIDE INJECTION Discontinued 2020-02-13 2020-02-13 106170
TEVA-HYDROMORPHONE 8MG TABLET Discontinued 2020-02-13 2020-02-13 106167
TEVA-HYDROMORPHONE 4MG TABLET Discontinued 2020-02-13 2020-02-13 106164
TEVA-HYDROMORPHONE 2MG TABLET Discontinued 2020-02-13 2020-02-13 106161
TEVA-HYDROMORPHONE 1MG TABLET Discontinued 2020-02-13 2020-02-13 106158
GEMCITABINE FOR INJECTION Discontinued 2020-02-13 2020-02-13 106155
RATIO-SALBUTAMOL Discontinued 2020-02-13 2020-02-13 106151
RATIO-NYSTATIN 100000UNIT CREAM Discontinued 2020-02-13 2020-02-13 106148
TEVA-ATENOLOL 100MG TABLET Discontinued 2020-02-13 2020-02-13 106145
TEVA-ATENOLOL 50MG TABLET Discontinued 2020-02-13 2020-02-13 106142
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106139
TEVA-RANITIDINE Discontinued 2020-02-13 2020-02-13 106136
TEVA-TRIMEL 400MG 80MG TABLET Discontinued 2020-02-13 2020-02-13 106133
TEVA-VENLAFAXINE XR 75MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-02-07 2020-02-08 105537
TEVA-LEVETIRACETAM 500MG TABLET Discontinued 2020-01-24 2020-01-24 104304
TEVA-QUININE 300MG CAPSULE Discontinued 2020-01-24 2020-01-24 104294
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104283
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Discontinued 2020-01-24 2020-01-24 104277
TEVA-ARIPIPRAZOLE 5MG TABLET Discontinued 2020-01-24 2020-01-24 104263

Showing 81 to 100 of 250